NCT07337291

Brief Summary

This prospective, single-center, interventional study enrolled 400 cirrhotic patients with large or complex common bile duct (CBD) stones that could not be removed during an initial Endoscopic Retrograde Cholangiopancreatography (ERCP). The study compared four different plastic biliary stenting strategies (single 10 Fr, double 10 Fr, single 11.5 Fr, and single 10 Fr pigtail stents) to determine the optimal approach for facilitating successful stone clearance in a subsequent ERCP and minimizing complications in this high-risk patient population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
Last Updated

January 13, 2026

Status Verified

December 1, 2025

Enrollment Period

3 years

First QC Date

January 1, 2026

Last Update Submit

January 1, 2026

Conditions

Keywords

ERCPBiliary StentDouble StentLiver CirrhosisNon-Retrievable StonesHigh-Risk Patients

Outcome Measures

Primary Outcomes (2)

  • Stent Patency

    Time from stent placement until clinical or biochemical evidence of stent occlusion (e.g., cholangitis, elevated liver enzymes, or imaging findings).

    6 months

  • Successful Stone Clearance in Second ERCP

    The proportion of patients in each group achieving complete clearance of common bile duct stones during the second, planned ERCP session.

    6 months

Secondary Outcomes (3)

  • Incidence of Procedure-Related Complications

    From stenting until 30 days after the second ERCP.

  • Reduction in Stone Size

    6 months

  • All-Cause Mortality

    12 months

Study Arms (4)

Single 10 Fr Plastic Stent

EXPERIMENTAL

Placement of a single 10 French (Fr), 10 cm plastic biliary stent.

Device: Single 10 Fr Plastic Biliary Stent

Double 10 Fr Plastic Stents

EXPERIMENTAL

Placement of two 10 French (Fr), 10 cm plastic biliary stents side-by-side.

Device: Two 10 Fr Plastic Biliary Stent

Single 11.5 Fr Plastic Stent

EXPERIMENTAL

Placement of a single 11.5 French (Fr), 10 cm plastic biliary stent.

Device: Single 11.5 Fr Plastic Biliary Stent

Single 10 Fr Pigtail Stent

EXPERIMENTAL

Placement of a single 10 French (Fr), 10 cm pigtail plastic biliary stent.

Device: Single 10 Fr Pigtail Stent

Interventions

Single 10 Fr, 10 cm plastic stent placed endoscopically.

Single 10 Fr Plastic Stent

Two 10 Fr, 10 cm plastic stents placed endoscopically.

Double 10 Fr Plastic Stents

Single 11.5 Fr, 10 cm plastic stent placed endoscopically.

Single 11.5 Fr Plastic Stent

Single 10 Fr, 10 cm pigtail plastic stent placed endoscopically.

Single 10 Fr Pigtail Stent

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with established liver cirrhosis.
  • Presence of large or complex common bile duct (CBD) stones that were non-retrievable during the initial ERCP.
  • Classified as high-risk due to moderate to severe liver disease and/or substantial comorbidities, making them unable to safely tolerate extended endoscopic procedures or surgical intervention.
  • Clinically stable and capable of undergoing the scheduled diagnostic and therapeutic procedures.
  • Provided signed informed consent before enrollment.

You may not qualify if:

  • Non-cirrhotic patients.
  • Patients with non-calculous causes of biliary obstruction (e.g., portal biliopathy, benign biliary strictures, or malignant biliary obstruction).
  • Acute suppurative cholangitis.
  • Contraindications to ERCP.
  • Inability to complete the scheduled 12-month follow-up time.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Liver Institute, Menoufia University, Egypt.

Shibīn al Kawm, Menoufia, 32511, Egypt

Location

Related Publications (3)

  • Lee TH, Han JH, Kim HJ, Park SM, Park SH, Kim SJ. Is the addition of choleretic agents in multiple double-pigtail biliary stents effective for difficult common bile duct stones in elderly patients? A prospective, multicenter study. Gastrointest Endosc. 2011 Jul;74(1):96-102. doi: 10.1016/j.gie.2011.03.005. Epub 2011 Apr 30.

    PMID: 21531412BACKGROUND
  • Horiuchi A, Nakayama Y, Kajiyama M, Kato N, Kamijima T, Graham DY, Tanaka N. Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc. 2010 Jun;71(7):1200-1203.e2. doi: 10.1016/j.gie.2009.12.055. Epub 2010 Apr 18.

    PMID: 20400079BACKGROUND
  • Binmoeller KF, Schafer TW. Endoscopic management of bile duct stones. J Clin Gastroenterol. 2001 Feb;32(2):106-18. doi: 10.1097/00004836-200102000-00004.

    PMID: 11205644BACKGROUND

MeSH Terms

Conditions

CholedocholithiasisLiver Cirrhosis

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisLiver DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 1, 2026

First Posted

January 13, 2026

Study Start

January 1, 2022

Primary Completion

January 1, 2025

Study Completion

January 1, 2026

Last Updated

January 13, 2026

Record last verified: 2025-12

Locations